- Stocks
- Healthcare
- NASDAQ: FREQ

Price (delayed)

$9.97

Market cap

$341.16M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.26

Enterprise value

$216.6M

FREQ's quick ratio has surged by 119% year-on-year and by 25% since the previous quarter

Frequency Therapeutics's equity has decreased by 8% from the previous quarter but it has increased by 8% YoY

FREQ's net income has dropped by 135% year-on-year and by 58% since the previous quarter

FREQ's EPS has shrunk by 54% QoQ

What are the main financial stats of FREQ

Market
Valuations
Earnings

Shares outstanding

34.22M

Market cap

$341.16M

Enterprise value

$216.6M

Price to earnings (P/E)

N/A

Price to book (P/B)

1.92

Price to sales (P/S)

9.9

EV/EBIT

N/A

EV/EBITDA

N/A

EV/Sales

6.3

Revenue

$34.37M

EBIT

-$42.07M

EBITDA

-$40.11M

Free cash flow

-$68.17M

Per share
Balance sheet
Liquidity

EPS

-$1.26

Free cash flow per share

-$2

Book value per share

$5.19

Revenue per share

$1.01

TBVPS

$7.08

Total assets

$241.51M

Total liabilities

$64.1M

Debt

$46.48M

Equity

$177.41M

Working capital

$181.16M

Debt to equity

0.26

Current ratio

10.58

Quick ratio

10.4

Net debt/EBITDA

3.11

Margins
Efficiency
Dividend

EBITDA margin

-116.7%

Gross margin

100%

Net margin

-122.1%

Operating margin

-122.5%

Return on assets

-17.8%

Return on equity

-23%

Return on invested capital

-158.3%

Return on capital employed

-18.9%

Return on sales

-122.4%

Dividend yield

N/A

DPS

N/A

Payout ratio

N/A

How has the Frequency Therapeutics stock price performed over time

Intraday

-1.68%

1 week

3.42%

1 month

15.53%

1 year

-55.29%

YTD

-71.72%

QTD

4.95%

How have Frequency Therapeutics's revenue and profit performed over time

Revenue

$34.37M

Gross profit

$34.37M

Operating income

-$42.09M

Net income

-$41.97M

Gross margin

100%

Net margin

-122.1%

Frequency Therapeutics's net margin has plunged by 148% YoY and by 70% from the previous quarter

FREQ's net income has dropped by 135% year-on-year and by 58% since the previous quarter

FREQ's operating margin has shrunk by 117% YoY and by 64% QoQ

FREQ's operating income has dropped by 106% year-on-year and by 53% since the previous quarter

What is Frequency Therapeutics's growth rate over time

What is Frequency Therapeutics stock price valuation

P/E

N/A

P/B

1.92

P/S

9.9

EV/EBIT

N/A

EV/EBITDA

N/A

EV/Sales

6.3

FREQ's EPS has shrunk by 54% QoQ

The stock's price to book (P/B) is 51% less than its last 4 quarters average of 3.9

Frequency Therapeutics's equity has decreased by 8% from the previous quarter but it has increased by 8% YoY

The stock's price to sales (P/S) is 48% less than its last 4 quarters average of 19.1

Frequency Therapeutics's revenue has decreased by 7% QoQ and by 5% YoY

How efficient is Frequency Therapeutics business performance

FREQ's ROS has shrunk by 119% YoY and by 65% QoQ

FREQ's return on assets has dropped by 102% year-on-year and by 55% since the previous quarter

The return on equity has dropped by 100% year-on-year and by 55% since the previous quarter

What is FREQ's dividend

DPS

N/A

Dividend yield

N/A

Payout ratio

N/A

There are no recent dividends present for FREQ.

How did Frequency Therapeutics financials performed over time

The current ratio has soared by 120% YoY and by 25% from the previous quarter

FREQ's quick ratio has surged by 119% year-on-year and by 25% since the previous quarter

Frequency Therapeutics's debt is 74% less than its equity

FREQ's debt to equity is up by 8% since the previous quarter

Frequency Therapeutics's equity has decreased by 8% from the previous quarter but it has increased by 8% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.